| A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication S Pambudi, N Kawashita, S Phanthanawiboon, MD Omokoko, ... Biochemical and Biophysical Research Communications 440 (3), 393-398, 2013 | 66 | 2013 |
| Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection T Sasaki, C Setthapramote, T Kurosu, M Nishimura, A Asai, MD Omokoko, ... Antiviral research 98 (3), 423-431, 2013 | 57 | 2013 |
| Early events in hepatitis B virus infection: From the cell surface to the nucleus CN Hayes, Y Zhang, GN Makokha, MZ Hasan, MD Omokoko, K Chayama Journal of gastroenterology and hepatology 31 (2), 302-309, 2016 | 45 | 2016 |
| Highly conserved region 141‒168 of the NS1 protein is a new common epitope region of dengue virus P Masrinoul, MO Diata, S Pambudi, K Limkittikul, K Ikuta, T Kurosu Japanese journal of infectious diseases 64 (2), 109-115, 2011 | 31 | 2011 |
| Seroprevalence of human T‐lymphotropic virus (HTLV) in blood donors in sub‐Saharan Africa: A systematic review and meta‐analysis AM Ngoma, MD Omokoko, PB Mutombo, KE Nollet, H Ohto Vox Sanguinis 114 (5), 413-425, 2019 | 24 | 2019 |
| A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients MD Omokoko, S Pambudi, S Phanthanawiboon, P Masrinoul, ... The American journal of tropical medicine and hygiene 91 (1), 146, 2014 | 22 | 2014 |
| Serotype-specific anti-dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production P Masrinoul, MD Omokoko, S Pambudi, K Ikuta, T Kurosu Viral Immunology 26 (4), 250-258, 2013 | 14 | 2013 |
| Population‐based prevalence of human T‐lymphotropic virus type 1 in sub‐Saharan Africa: a systematic review and meta‐analysis AM Ngoma, MD Omokoko, PB Mutombo, ES Mvika, JM Muwonga, ... Tropical Medicine & International Health 24 (11), 1277-1290, 2019 | 11 | 2019 |
| Chimeric flavivirus enables evaluation of antibodies against dengue virus envelope protein in vitro and in vivo T Kurosu, K Hanabara, A Asai, S Pambudi, S Phanthanawiboon, ... Scientific Reports 10 (1), 21561, 2020 | 6 | 2020 |
| Prevalence and molecular epidemiology of human T-lymphotropic virus type 1 among women attending antenatal clinics in Sub-Saharan Africa: A systematic review and meta-analysis AM Ngoma, PB Mutombo, MD Omokoko, ES Mvika, KE Nollet, H Ohto The American Journal of Tropical Medicine and Hygiene 101 (4), 908, 2019 | 5 | 2019 |
| Construction of a high-yield dengue virus by replacing nonstructural proteins 3–4B without increasing virulence S Phanthanawiboon, S Pambudi, MD Omokoko, K Hanabara, ... Biochemical and biophysical research communications 495 (1), 1221-1226, 2018 | 2 | 2018 |
| Chimeric flavivirus causes vascular leakage and bone marrow suppression in a mouse model T Kurosu, K Hanabara, A Asai, S Pambudi, S Phanthanawiboon, ... Biochemical and Biophysical Research Communications 659, 54-61, 2023 | 1 | 2023 |
| Serotype-Specific Anti-Dengue Virus NS1 Mouse Antibodies Cross-React with prM and Are Potentially Involved in Virus Production MD Omokoko | | 2014 |
| Serotype-Specific Anti-Dengue Virus NS1 Mouse MD Omokoko | | |
Takeshi KurosuNational Institute of Infectious Diseases在 niid.go.jp 的电子邮件经过验证
